Edge Rankings

Restart Life Sciences Stock Price, Quotes and Forecasts | OTC:NMLSF | Benzinga

Q: How do I buy Restart Life Sciences (NMLSF) stock?

You can purchase shares of Restart Life Sciences (OTCPK:NMLSF) through any online brokerage. View our list of the best stock brokerages

Q: Who are Restart Life Sciences (NMLSF) competitors?

There are no as such competitors for Restart Life Sciences.

Q: What is the forecast, or price target, for Restart Life Sciences (NMLSF) stock?

There is no analysis for Restart Life Sciences to provide a consensus price target.

Q: What is the current price for Restart Life Sciences (NMLSF)?

The stock price for Restart Life Sciences (OTCPK: NMLSF) is $0.03 last updated April 22, 2025 at 9:30 AM EDT.

Q: Does Restart Life Sciences (NMLSF) pay a dividend?

There are no upcoming dividends for Restart Life Sciences.

Q: When is Restart Life Sciences (OTCPK:NMLSF) reporting earnings?

Restart Life Sciences does not have any upcoming earnings scheduled.

Q: Is Restart Life Sciences (NMLSF) going to split?

There is no upcoming split for Restart Life Sciences.

Q: What sector and industry does Restart Life Sciences (NMLSF) operate in?

Restart Life Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.

Explore Restart Life Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NMLSF.

Open	$0.03
Close	-
Volume / Avg.	1.70K / 11.09K
Day Range	$0.03 - $0.03
52 Wk Range	0.02 - 0.15
Market Cap	$543.81K
P/E Ratio	8.32
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).

Lara Goldstein

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism

The partnership between contract research organization KGK Sciences Inc. and Nova Mentis Life Science Corp. (OTC: NMLSF) has started <

Lara Goldstein

Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and added to the list of measures calling for some sort of psychedelics legalization, while some of the already filed ones continue progressing and others get a thumbs down.

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.03
Close	-
Volume / Avg.	1.70K / 11.09K
Day Range	$0.03 - $0.03
52 Wk Range	0.02 - 0.15
Market Cap	$543.81K
P/E Ratio	8.32
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

About

Sector

Healthcare

Industry

N/A

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's healt...

Got Questions? Ask

How is NMLSF's ROE trending?

How is the earnings season affecting NMLSF?

What does NMLSF's DCF valuation show?

What is NMLSF's 7 days volume trend?

What is NMLSF's average daily volume?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Restart Life Sciences (NMLSF) stock?

You can purchase shares of Restart Life Sciences (OTCPK:NMLSF) through any online brokerage.

View our list of the best stock brokerages

Who are Restart Life Sciences (NMLSF) competitors?

There are no as such competitors for Restart Life Sciences.

What is the forecast, or price target, for Restart Life Sciences (NMLSF) stock?

There is no analysis for Restart Life Sciences to provide a consensus price target.

What is the current price for Restart Life Sciences (NMLSF)?

The stock price for Restart Life Sciences (OTCPK: NMLSF) is $0.03 last updated April 22, 2025 at 9:30 AM EDT.

Does Restart Life Sciences (NMLSF) pay a dividend?

There are no upcoming dividends for Restart Life Sciences.

When is Restart Life Sciences (OTCPK:NMLSF) reporting earnings?

Restart Life Sciences does not have any upcoming earnings scheduled.

Is Restart Life Sciences (NMLSF) going to split?

There is no upcoming split for Restart Life Sciences.

What sector and industry does Restart Life Sciences (NMLSF) operate in?

Restart Life Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.

Comments

Restart Life Sciences Stock Price, Quotes and Forecasts

Restart Life Sciences (NMLSF) Forecast

Edge Rankings

Restart Life Sciences Stock Price, Quotes and Forecasts | OTC:NMLSF | Benzinga

Recent News

Financials

Compare

FAQ

How do I buy Restart Life Sciences (NMLSF) stock?

Who are Restart Life Sciences (NMLSF) competitors?

What is the forecast, or price target, for Restart Life Sciences (NMLSF) stock?

What is the current price for Restart Life Sciences (NMLSF)?

Does Restart Life Sciences (NMLSF) pay a dividend?

When is Restart Life Sciences (OTCPK:NMLSF) reporting earnings?

Is Restart Life Sciences (NMLSF) going to split?

What sector and industry does Restart Life Sciences (NMLSF) operate in?

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell